Vetter’s Newest Facility Successfully Completes FDA Inspection
News Mar 28, 2013
Vetter has announced that its new center for visual inspection and logistics passed its first GMP inspection by the U.S. Food and Drug Administration (FDA).
The inspection was conducted March 11 through 14 to ensure the facility is in compliance with good manufacturing practices.
The facility was already granted manufacturing approval and cGMP certification for Europa from the RP Tuebingen, Germany in 2012.
The 18,000-square-meter facility, known as Ravensburg Vetter West (RVW), began operations in April 2012.
The site provides high-bay warehousing for cold storage and room-temperature products, as well as visual inspection.
Featuring technology, which helps adapted to the needs of the separate supply and manufacturing processes, RVW also harnesses extensive use of renewable energy sources, including photovoltaic and geothermal.
“We’re pleased with the outcome of Ravensburg Vetter West’s first FDA GMP inspection,” said managing director Thomas Otto.
Otto continued, “We at Vetter work diligently to meet regulatory requirements. Maintaining high quality standards is a job we take seriously to be a reliable and efficient partner for our customers.”
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Alzheimer’s Drug Discovery Foundation Announces $1.8M in New FundingNews
The Alzheimer’s Drug Discovery Foundation (ADDF) announces nearly $1.8 million in new funding, which reflects a commitment to advancing drugs in or near human clinical trials. All five funded programs are potential treatments for Alzheimer’s disease and other forms of dementia.READ MORE